Precursor%20Cell%20Lymphoblastic%20Leukemia-Lymphoma
Showing 26 - 50 of >10,000
T-Acute Lymphoblastic Leukemia, Adult T Lymphoblastic Lymphoma Trial in United States (BL-8040, Nelarabine)
Terminated
- T-Acute Lymphoblastic Leukemia
- Adult T Lymphoblastic Lymphoma
-
Saint Louis, Missouri
- +1 more
Jan 18, 2023
Leukemia, Acute Lymphoblastic Leukemia Trial in New York (gene-modified T cells targeted)
Active, not recruiting
- Leukemia
- Acute Lymphoblastic Leukemia
- gene-modified T cells targeted
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Feb 1, 2023
Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission Trial in São Paulo (Bortezomib)
Not yet recruiting
- Acute Lymphoblastic Leukemia, in Relapse
- Acute Lymphoblastic Leukemia With Failed Remission
-
São Paulo, SP, BrazilInstituto do Cancer do Estado de Sao Paulo
Sep 12, 2023
Cytarabine+Thiotepa + Fludarabine + Busulfan, T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial in Hangzhou
Recruiting
- Cytarabine+Thiotepa + Fludarabine + Busulfan
- T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
- cytarabine+thiotepa+ fludarabine + busulfan
-
Hangzhou, ChinaThe First Affiliated Hospital, College of Medicine, Zhejiang Uni
Oct 26, 2022
Pediatric Acute Lymphoblastic Leukemia, Leukemia, Acute Lymphoblastic Leukemia Trial in Boston (Sleep ALL Night)
Not yet recruiting
- Pediatric Acute Lymphoblastic Leukemia
- +2 more
- Sleep ALL Night
-
Boston, Massachusetts
- +1 more
May 10, 2023
Non-hodgkin Lymphoma, Acute Lymphoblastic Leukaemia, Chronic Lymphocytic Leukemia Trial in Tianjin (CC312)
Recruiting
- Non-hodgkin Lymphoma
- +2 more
- CC312
-
Tianjin, Tianjin, ChinaInstituteHBDH
Sep 12, 2023
PET-CT Imaging in Relapsed/Refractory Acute Leukemias
Not yet recruiting
- B Cell
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 4, 2023
Infective Complications and Outcome of ALL Treated With INO
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +4 more
- (no location specified)
Aug 29, 2023
T-cell Acute Lymphoblastic Leukemia/Lymphoma Trial in Beijing (Senl-T7)
Recruiting
- T-cell Acute Lymphoblastic Leukemia/Lymphoma
- Senl-T7
-
Beijing, Hebei, ChinaHebei yanda Hospital
Nov 22, 2022
Newly-diagnosed Ph+ Acute Lymphoblastic Leukemia Trial in Xi'an (Olverembatinib plus venetoclax and dexamethasone)
Recruiting
- Newly-diagnosed Ph+ Acute Lymphoblastic Leukemia
- Olverembatinib plus venetoclax and dexamethasone
-
Xi'an, Shannxi, ChinaDepartment of Hematology, Xijing Hospital, Fourth Military Medic
Oct 9, 2023
Acute Lymphoblastic Leukemia Trial in Houston (Blinatumomab, Hematopoietic Cell Transplantation)
Completed
- Acute Lymphoblastic Leukemia
- Blinatumomab
- Hematopoietic Cell Transplantation
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 30, 2022
Acute Lymphoblastic Leukemia, Hodgkin Disease, Allogeneic Stem Cell Transplantation Trial in Erlangen (Low-field magnetic
Recruiting
- Acute Lymphoblastic Leukemia
- +2 more
- Low-field magnetic resonance imaging
- +3 more
-
Erlangen, Bavaria, GermanyDepartment of Pediatrics and Adolescent Medicine
Oct 23, 2023
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +6 more
- Miltenyi CliniMACS Prodigy ® system
- (no location specified)
Mar 23, 2023
Acute Lymphoblastic Leukemia Trial (chidamide, Venetoclax Oral Tablet, Inotuzumab Ozogamicin)
Not yet recruiting
- Acute Lymphoblastic Leukemia
- chidamide
- +2 more
- (no location specified)
Oct 19, 2023
Clinical Significance of Occult Central Nervous System
Recruiting
- Acute Lymphoblastic Leukemia
- cerebrospinal fluids exams
-
Roma, RM, ItalyTor Vergata University
Mar 17, 2023
T-cell Acute Lymphoblastic Leukemia Trial in Beijing (CD5 CAR-T)
Recruiting
- T-cell Acute Lymphoblastic Leukemia
- CD5 CAR-T
-
Beijing, Beijing, ChinaXuanwu Hospital Capital Medical University
Oct 23, 2022
MRD Detection by NGS in Pediatric B-ALL
Completed
- Acute Lymphoblastic Leukemia, Pediatric, Next Generation Sequencing
- MRD
-
Hangzhou, Zhejiang, ChinaThe Children's Hospital of Zhejiang University School of Medicin
Jul 25, 2023
Allogeneic Hematopoietic Stem Cell Transplantation, Acute Lymphoblastic Leukemia Trial in Suzhou (VEN+AZA+Modified BUCY)
Recruiting
- Allogeneic Hematopoietic Stem Cell Transplantation
- Acute Lymphoblastic Leukemia
- VEN+AZA+Modified BUCY
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Apr 10, 2023
T-cell Acute Lymphoblastic Leukemia, T-cell Acute Lymphoblastic Lymphoma, Acute Myeloid Leukemia Trial in Beijing, Shenzhen,
Recruiting
- T-cell Acute Lymphoblastic Leukemia
- +3 more
- Universal CD7-specific CAR gene-engineered T cells
-
Beijing, Beijing, China
- +2 more
Aug 17, 2023
Next-generation Sequencing in Pediatric B-ALL Children Patients
Not yet recruiting
- Acute Lymphoblastic Leukemia, Pediatric
- (no location specified)
Apr 19, 2023
Lymphoblastic Leukemia Trial in Palo Alto (Dexamethasone, Mitoxantrone, PEG asparaginase)
Not yet recruiting
- Lymphoblastic Leukemia
- Dexamethasone
- +8 more
-
Palo Alto, CaliforniaStanford University
Apr 27, 2023
Mantle Cell Lymphoma, Acute Lymphoblastic Leukemia Trial (Brexucabtagene Autoleucel)
Available
- Mantle Cell Lymphoma
- Acute Lymphoblastic Leukemia
- Brexucabtagene Autoleucel
- (no location specified)
Mar 17, 2023
T-lymphoblastic Lymphoma, Relapsed Disease, Refractory Lymphoma Trial in Shanghai (BCL2 Inhibitor plus IM2 regimen)
Recruiting
- T-lymphoblastic Lymphoma
- +5 more
- BCL2 Inhibitor plus IM2 regimen
-
Shanghai, Shanghai, ChinaShanghai General hospital,Shanghai Jiao Tong University School o
Jan 10, 2023
B-cell Acute Lymphoblastic Leukemia Trial (single dose of CNCT19)
Not yet recruiting
- B-cell Acute Lymphoblastic Leukemia
- single dose of CNCT19
- (no location specified)
Dec 19, 2022
Acute Lymphoblastic Leukemia Trial in Tianjin (CN201)
Recruiting
- Acute Lymphoblastic Leukemia
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Oct 14, 2022